Your session is about to expire
← Back to Search
Mesh Reconstruction for Breast Cancer
Study Summary
This trial is studying the use of surgical mesh in pre-pectoral tissue expander to breast implant reconstruction.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2016 Phase 4 trial • 20 Patients • NCT02450383Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am having breast reconstruction with an implant in one surgery.My surgery showed that immediate reconstruction in front of the chest muscle isn't suitable due to poor skin condition.I have had a mastectomy for prevention or cancer treatment.I am a woman aged 22-75 planning immediate breast reconstruction with tissue expanders.My surgery will save the nipple and skin.I plan to have reconstruction surgery at a later time.I am having both breasts reconstructed, with one being placed under the muscle.
- Group 1: Control
- Group 2: Acellular Dermal Matrix
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could I join this research endeavor?
"This ongoing medical trial is searching for 120 breast cancer patients between the ages of 22 and 75."
Are there any vacancies remaining for those wishing to enroll in this trial?
"Affirmative, clinicaltrials.gov conveys that this trial is recruiting participants. The original post was on October 1st 2022 and the study has been updated more recently as of September 13th 2022. There are 120 open spots at one location for this medical experiment."
What is the upper threshold of participants in this trial?
"Affirmative. According to clinicaltrials.gov, this research project is still recruiting participants. The trial was initially published on October 1st 2022 and most recently updated on September 13th 2022. 120 individuals are being sought from a single medical site for the study's purposes."
Is eligibility restricted to individuals aged 50 or younger for this trial?
"This trial requires participants between the ages of 22 to 75. If your age falls outside this range, there are 79 trials for young adults and 1598 studies suitable for seniors."
Share this study with friends
Copy Link
Messenger